Literature DB >> 16733613

Antimicrobial resistance of Neisseria gonorrhoeae isolates from the Stuttgart and Heidelberg areas of southern Germany.

M Enders1, A Turnwald-Maschler, T Regnath.   

Abstract

The aim of the present study was to determine prospectively the antimicrobial susceptibility of Neisseria gonorrhoeae strains collected in southern Germany (Heidelberg and Stuttgart areas). Sixty-five N. gonorrhoeae strains, isolated between July 2004 and June 2005 from patients with uncomplicated gonorrhoea, were tested. Minimum inhibitory concentrations of penicillin, tetracycline, ciprofloxacin, azithromycin, spectinomycin, ceftriaxone, and cefixime were determined by the E test. All isolates were fully susceptible to ceftriaxone, cefixime, and spectinomycin. However, 21.5% (14/65), 29.2% (19/65), and 47.7% (31/65) of isolates were resistant to penicillin (>2.0 mg/l), tetracycline (>2.0 mg/l), and ciprofloxacin (>1.0 mg/l), respectively. Critical MICs of azithromycin (>1.0 mg/l, as defined by the Neisseria Reference Laboratory at the Centers for Disease Control) were found for five (7.7%) N. gonorrhoeae isolates. These data indicate a high prevalence of N. gonorrhoeae strains resistant to the antimicrobial agents currently used to treat gonococcal infections in the Heidelberg and Stuttgart areas. Even though the findings may not be representative of the general population in Germany, they nevertheless illustrate the need to establish an antimicrobial resistance surveillance system in order to control gonorrhoea effectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16733613     DOI: 10.1007/s10096-006-0134-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  16 in total

1.  [Rational use of oral antibiotics. Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy].

Authors:  Friedrich Vogel; Horst Scholz; B al-Nawas; W Elies; M Kresken; H Lode; O Müller; K G Naber; E Petersen; P Shah; F Sörgel; W Stille; C Tauchnitz; M Trautmann; U Ullmann; H Wacha; B Wiedemann
Journal:  Med Monatsschr Pharm       Date:  2002-06

2.  Efficacy of azithromycin 1g single dose in the management of uncomplicated gonorrhoea.

Authors:  Amgad R Habib; Rufus Fernando
Journal:  Int J STD AIDS       Date:  2004-04       Impact factor: 1.359

3.  Amplified HIV transmission and new approaches to HIV prevention.

Authors:  Myron S Cohen; Christopher D Pilcher
Journal:  J Infect Dis       Date:  2005-03-30       Impact factor: 5.226

4.  Azithromycin and erythromycin resistant Neisseria gonorrhoeae following treatment with azithromycin.

Authors:  H Young; A Moyes; A McMillan
Journal:  Int J STD AIDS       Date:  1997-05       Impact factor: 1.359

5.  Epidemiology of penicillin-resistant Neisseria gonorrhoeae in Frankfurt, Germany.

Authors:  V Schäfer; R Enzensberger; C Schneider; J Rickmann; H Nitschke-Ozbay; V Brade
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-10       Impact factor: 3.267

6.  Building a sentinel surveillance system for sexually transmitted infections in Germany, 2003.

Authors:  V Bremer; U Marcus; A Hofmann; O Hamouda
Journal:  Sex Transm Infect       Date:  2005-04       Impact factor: 3.519

7.  Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003.

Authors:  Charlotte K Kent; Janice K Chaw; William Wong; Sally Liska; Steven Gibson; Gregory Hubbard; Jeffrey D Klausner
Journal:  Clin Infect Dis       Date:  2005-05-26       Impact factor: 9.079

8.  Comparative studies of azithromycin in skin and soft-tissue infections and sexually transmitted infections by Neisseria and Chlamydia species.

Authors:  A Lassus
Journal:  J Antimicrob Chemother       Date:  1990-01       Impact factor: 5.790

9.  A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group.

Authors:  D H Martin; T F Mroczkowski; Z A Dalu; J McCarty; R B Jones; S J Hopkins; R B Johnson
Journal:  N Engl J Med       Date:  1992-09-24       Impact factor: 91.245

Review 10.  Drugs five years later. Spectinomycin.

Authors:  W M McCormack; M Finland
Journal:  Ann Intern Med       Date:  1976-06       Impact factor: 25.391

View more
  9 in total

1.  High rates of quinolone-resistant strains of Shigella sonnei in HIV-infected MSM.

Authors:  C Hoffmann; H Sahly; A Jessen; P Ingiliz; H-J Stellbrink; S Neifer; K Schewe; S Dupke; A Baumgarten; A Kuschel; I Krznaric
Journal:  Infection       Date:  2013-07-13       Impact factor: 3.553

2.  Highly variable use of diagnostic methods for sexually transmitted infections-results of a nationwide survey, Germany 2005.

Authors:  Andreas Gilsdorf; Alexandra Hofmann; Osamah Hamouda; Viviane Bremer
Journal:  BMC Infect Dis       Date:  2010-04-19       Impact factor: 3.090

3.  Cephalosporin Resistance in Neisseria gonorrhoeae.

Authors:  Manju Bala; Seema Sood
Journal:  J Glob Infect Dis       Date:  2010-09

Review 4.  An insight into the drug resistance profile & mechanism of drug resistance in Neisseria gonorrhoeae.

Authors:  Achchhe Lal Patel; Uma Chaudhry; Divya Sachdev; Poonam Nagpal Sachdeva; Manju Bala; Daman Saluja
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

5.  Exploring quinolone resistance-determining region in Neisseria gonorrhoeae isolates from across India.

Authors:  Seema Sood; Madhav Agarwal; Manju Bala; Neeraj Mahajan; Rajendra Singh; Arti Kapil; Vishnubhatla Sreenivas; R J Ram; Hemanta Kumar Kar; Vinod Kumar Sharma
Journal:  Indian J Med Res       Date:  2017-07       Impact factor: 2.375

6.  Antimicrobial resistance of Neisseria gonorrhoeae isolates in south-west Germany, 2004 to 2015: increasing minimal inhibitory concentrations of tetracycline but no resistance to third-generation cephalosporins.

Authors:  Thomas Regnath; Thomas Mertes; Ralf Ignatius
Journal:  Euro Surveill       Date:  2016-09-08

Review 7.  On the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infections.

Authors:  R Matthew Chico; Berkin B Hack; Melanie J Newport; Enesia Ngulube; Daniel Chandramohan
Journal:  Expert Rev Anti Infect Ther       Date:  2013-11-06       Impact factor: 5.091

8.  Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.

Authors:  Susanne Buder; Sandra Dudareva; Klaus Jansen; Anna Loenenbach; Sergejs Nikisins; Andrea Sailer; Eva Guhl; Peter K Kohl; Viviane Bremer
Journal:  BMC Infect Dis       Date:  2018-01-17       Impact factor: 3.090

9.  Molecular epidemiological typing of Neisseria gonorrhoeae isolates identifies a novel association between genogroup G10557 (G7072) and decreased susceptibility to cefixime, Germany, 2014 to 2017.

Authors:  Sebastian Banhart; Klaus Jansen; Susanne Buder; Thalea Tamminga; Sébastien Calvignac-Spencer; Tanja Pilz; Andrea Martini; Sandra Dudareva; Sergejs Nikisins; Kerstin Dehmel; Gabriele Zuelsdorf; Eva Guhl; Ingeborg Graeber; Peter K Kohl; Magnus Unemo; Viviane Bremer; Dagmar Heuer
Journal:  Euro Surveill       Date:  2020-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.